Home Cart Sign in  
Chemical Structure| 594839-88-0 Chemical Structure| 594839-88-0

Structure of Tafamidis
CAS No.: 594839-88-0

Chemical Structure| 594839-88-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tafamidis is a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.

Synonyms: PF-06291826

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tafamidis

CAS No. :594839-88-0
Formula : C14H7Cl2NO3
M.W : 308.12
SMILES Code : O=C(C1=CC=C2N=C(C3=CC(Cl)=CC(Cl)=C3)OC2=C1)O
Synonyms :
PF-06291826
MDL No. :MFCD16621109
InChI Key :TXEIIPDJKFWEEC-UHFFFAOYSA-N
Pubchem ID :11001318

Safety of Tafamidis

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Tafamidis functions as a potent and selective stabilizer of transthyretin (TTR), demonstrating similar potency and efficacy to the mutant homotetramers V30M-TTR, V122I-TTR, and wild type WT-TTR, with EC50 values ranging from 2.7 to 3.2 μM. Tafamidis also inhibits amyloidogenesis[1].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00925002 ATTR-PN PHASE3 COMPLETED 2020-07-08 Johns Hopkins Hospital, Baltim... More >>ore, Maryland, 21287, United States|FLENI, Ciudad Autonoma de Buenos aires, C1428AQK, Argentina|Hospital Universitário Clementino Fraga Filho -HUCFF Universidade Federal do Rio de Janeiro, Rio De Jameiro, R.j., 21941-913, Brazil|Centre d'Investigation Clinique, Creteil, 94010, France|Universitatsklinikum Muenster, Muenster, 48149, Germany|Centro per lo Studio e la Cura delle Amiloidosi Sistemiche IRCCS - Policlinico San Matteo, Pavia, 27100, Italy|Centro Hospitalar Lisboa Norte, EPE- Hospital de Santa Maria, Lisboa, 1649-028, Portugal|Unidade Clinica de Paramiloidose Centro Hospitalar do Porto, EPE - Hospital Geral de Santo António, Porto, 4099-001, Portugal|FAP-Teamet Familjar Amyloidos, Umea, 90185, Sweden Less <<
NCT05560555 Hereditary Transthyretin Amylo... More >>idosis (ATTRv)|Polyneuropathy Less << COMPLETED 2022-11-15 Hospital Universitari de Bellv... More >>itge, Barcelona, 08907, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|Hospital Son Llatzer, Palma de Mallorca, 07198, Spain Less <<
NCT06393465 Transthyretin Amyloidosis Card... More >>iomyopathy (ATTR-CM) Less << ACTIVE_NOT_RECRUITING 2025-02-28 Pfizer, New York, New York, 10... More >>001, United States Less <<
NCT02791230 Transthyretin (TTR) Amyloid Ca... More >>rdiomyopathy Less << PHASE3 COMPLETED 2023-11-02 The Kirklin Clinic of UAB Hosp... More >>ital, Birmingham, Alabama, 35233, United States|Cardiovascular Clinical Trials Unit (CCTU), Birmingham, Alabama, 35294, United States|University Hospital, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States|California Heart Center, Beverly Hills, California, 90211, United States|Cedars-Sinai Medical Care Foundation, Beverly Hills, California, 90211, United States|Altman Clinical Translational Research Institute, La Jolla, California, 92037, United States|University of California, San Diego, La Jolla, California, 92037, United States|Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States|University of California, San Diego Medical Center - Hillcrest, San Diego, California, 92103, United States|Center Adv Lab Medicine, San Diego, California, 92121, United States|UCSF Ambulatory Care Center, San Francisco, California, 94143, United States|University of California, San Francisco, California, 94143, United States|UCSF Cardiovascular Care and Prevention Center, San Francisco, California, 94158, United States|Stanford University Hospital and Clinics, Stanford, California, 94305, United States|Sylvester at Deerfield Beach, Deerfield Beach, Florida, 33136, United States|University of Miami Hospital & Clinics/Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Northwestern Medical Group, Chicago, Illinois, 60611, United States|Northwestern Memorial Hospital, Chicago, Illinois, 60611, United States|Advocate Christ Medical Center, Oak Lawn, Illinois, 60453, United States|University of Maryland, Baltimore, Baltimore, Maryland, 21201, United States|Johns Hopkins University, Baltimore, Maryland, 21287, United States|Boston Medical Center Investigational Pharmacy, Boston, Massachusetts, 02118, United States|Boston Medical Center, Boston, Massachusetts, 02118, United States|Boston University Medical Center, Boston, Massachusetts, 02118, United States|Michigan Medicine,University of Michigan, Ann Arbor, Michigan, 48109, United States|Mayo Clinic Hospital-Rochester, Rochester, Minnesota, 55902, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Newark Beth Israel Medical Center, Newark, New Jersey, 07112, United States|NYU Langone Health, New York, New York, 10016, United States|Center for Advanced Cardiac Care, New York, New York, 10032, United States|Columbia University Irving Medical Center, New York, New York, 10032, United States|Duke University, Durham, North Carolina, 27710, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|OHSU Center for Health and Healing, Portland, Oregon, 97239, United States|OHSU Research Pharmacy Services, Portland, Oregon, 97239, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, 19104, United States|Vanderbilt Univ. Med. Ctr, Nashville, Tennessee, 37232, United States|Huntsman Cancer Hospital, Salt Lake City, Utah, 84112, United States|University of Utah Hospitals & Clinics, Salt Lake City, Utah, 84132, United States|University of Utah, Division of Cardiovascular Medicine, Salt Lake City, Utah, 84132, United States|Instituto Cardiovascular de Buenos Aires, Ciudad Autónoma de Buenos Aires, C1428ART, Argentina|Westmead Hospital, Westmead, New South Wales, 2145, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, 4102, Australia|Eastern Health (Box Hill Hospital), Box Hill, Victoria, 3128, Australia|UZ Leuven, Leuven, 3000, Belgium|Hospital Universitário Clementino Fraga Filho (UFRJ), Rio de Janeiro, RJ, 21941-913, Brazil|University of Calgary/Foothills Medical Centre, Calgary, Alberta, T2N 4Z6, Canada|Vancouver General Hospital, Vancouver, British Columbia, V5Z 1M9, Canada|Toronto General Hospital, Toronto, Ontario, M5G 2C4, Canada|Montreal Heart Institute, Montreal, Quebec, H1T 1C8, Canada|Fakultni nemocnice u sv. Anny v Brne, Brno, 656 91, Czechia|Vseobecna fakultni nemocnice v Praze, Praha 2, 128 08, Czechia|Institut klinicke a experimentalni mediciny, Praha 4, 140 21, Czechia|Hopital de La Timone, Marseille, CAN, 13005, France|CHU Henri Mondor, Creteil, 94010, France|H?pital De La Timone, Marseille, 13385, France|Hopital Bichat, Paris, 75018, France|CHU de Rennes - Hopital Pontchaillou, Rennes, 35033, France|CHU de Rennes - H?pital Pontchaillou, Rennes, 35033, France|CHU de Toulouse - H?pital Rangueil, Toulouse, 31059, France|Medical University of Heidelberg, Heidelberg, 69120, Germany|Universit?tsklinikum Münster, Münster, 48149, Germany|Clinical Trial Pharmacy, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|Azienda Ospedaliero-Universitaria Policlinico S. Orsola Malpighi, Bologna, 40138, Italy|Azienda Ospedaliero-Universitaria Careggi, Firenze, 50134, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy|Kurume University Hospital, Kurume-shi, Fukuoka, 830-0011, Japan|Kumamoto University Hospital, Kumamoto-city, Kumamoto, 860-8556, Japan|Shinshu University Hospital, Nagano, 390-8621, Japan|University Medical Center Groningen, Groningen, 9713 GZ, Netherlands|Unidad de Insuficiencia Cardiaca Avanzada y Transplante Cardiaco, A Coruna, LA Coruna, 15006, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, 28222, Spain|Skellefte? Lasarett, Skellefte?, 931 86, Sweden|Akademiska Sjukhuset, Uppsala, 751 85, Sweden|Investigational Drug Services, Taipei, 100, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Taipei Veterans General Hospital, Taipei, 112, Taiwan|Barts Health NHS Trust, St Bartholomew's Hospital, London, EC1A 7BE, United Kingdom Less <<
NCT04814186 Transthyretin Amyloid Cardiomy... More >>opathy Less << PHASE4 COMPLETED 2023-10-16 Peking University First Hospit... More >>al, Beijing, Beijing, 100034, China|Peking University Third Hospital, Beijing, Beijing, 100191, China|Peking Union Medical College Hospital, Beijing, Beijing, 100730, China|Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, 430030, China|The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China|The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116014, China|West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China|The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China Less <<
NCT03662191 Healthy Volunteers PHASE1 COMPLETED 2019-01-10 Pfizer Clinical Research Unit,... More >> Brussels, B-1070, Belgium Less <<
NCT06086353 Transthyretin Amyloid Cardiomy... More >>opathy Less << RECRUITING 2025-04-30 Sri Jayadeva Institute of Card... More >>iovascular Sciences and Research, Bangalore, Karnataka, 560069, India|AIG Hospital, Hyderabad, 500032, India Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.25mL

0.65mL

0.32mL

16.23mL

3.25mL

1.62mL

32.45mL

6.49mL

3.25mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories